open access

Vol 77, No 6 (2009)
REVIEWS
Published online: 2009-11-30
Submitted: 2013-02-22
Get Citation

The impact of psychological variables on the presentation and progress of asthma and patient’s cognitive functions

Monika Talarowska, Antoni Florkowski, Piotr Gałecki, Janusz Szemraj, Krzysztof Zboralski, Tadeusz Pietras, Paweł Górski
Pneumonol Alergol Pol 2009;77(6):554-559.

open access

Vol 77, No 6 (2009)
REVIEWS
Published online: 2009-11-30
Submitted: 2013-02-22

Abstract

Chronic respiratory system diseases become serious public health problem all over the world. The most prevalent are obstructive diseases (asthma and COPD). The prevalence of asthma is still high and concern patients representing wide range of age and socio-economic status. Despite progress in diagnostic and therapeutic options several studies showed that asthma has an impact on health-related quality of life and patients’ coping. Asthma as chronic condition results in limitations of patients activity and social relations. Thus psychosocial variables, which may have an impact on asthma symptoms presentation and disease progress, should be considered. There are only few reports concerning cognitive functions in asthma. The aim of the study was to assess the potential impact of psychosocial factors on asthma symptoms presentation, and cognitive function in asthma patients.

Abstract

Chronic respiratory system diseases become serious public health problem all over the world. The most prevalent are obstructive diseases (asthma and COPD). The prevalence of asthma is still high and concern patients representing wide range of age and socio-economic status. Despite progress in diagnostic and therapeutic options several studies showed that asthma has an impact on health-related quality of life and patients’ coping. Asthma as chronic condition results in limitations of patients activity and social relations. Thus psychosocial variables, which may have an impact on asthma symptoms presentation and disease progress, should be considered. There are only few reports concerning cognitive functions in asthma. The aim of the study was to assess the potential impact of psychosocial factors on asthma symptoms presentation, and cognitive function in asthma patients.
Get Citation

Keywords

asthma; psychological variables; cognitive functions

About this article
Title

The impact of psychological variables on the presentation and progress of asthma and patient’s cognitive functions

Journal

Advances in Respiratory Medicine

Issue

Vol 77, No 6 (2009)

Pages

554-559

Published online

2009-11-30

Bibliographic record

Pneumonol Alergol Pol 2009;77(6):554-559.

Keywords

asthma
psychological variables
cognitive functions

Authors

Monika Talarowska
Antoni Florkowski
Piotr Gałecki
Janusz Szemraj
Krzysztof Zboralski
Tadeusz Pietras
Paweł Górski

References (66)
  1. Lis G, Breborowicz A, Swiatły A, et al. Prevalence of allergic diseases in schoolchildren in Krakow and Poznan (based on a standardized ISAAC questionnaire). Pneumonol Alergol Pol. 1997; 65(9-10): 621–627.
  2. Weiland SK, Björkstén B, Brunekreef B, et al. International Study of Asthma and Allergies in Childhood Phase II Study Group. Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods. Eur Respir J. 2004; 24(3): 406–412.
  3. Samoliński B, Hałat Z, Samolińska-Zawisza U, et al. Epidemiologia nieżytów nosa, astmy i AZS na podstawie badań ECRHS i ISAAC w Polsce. Alergia. 2007; 3: 10–12.
  4. Górski P. Czynniki środowiskowe w rozwoju astmy oskrzelowej i POChP. Pneumonol Alergol Pol. 1999; 67: 63–64.
  5. Patkowska J, Kuźniar T. Znaczenie badań nad jakością życia w chorobach alergicznych. Nowa Klinika. 1999; 6: 445–449.
  6. Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med. 2006; 355(21): 2226–2235.
  7. Ferguson CJ, Stanley M, Souchek J, et al. The utility of somatic symptoms as indicators of depression and anxiety in military veterans with chronic obstructive pulmonary disease. Depress Anxiety. 2006; 23(1): 42–49.
  8. Farnik-Brodzińska M, Pierzchała W. Jakość życia chorych z astmą oskrzelową. Choroby Układu Oddechowego. 1999; 4: 22–25.
  9. Farnik-Brodzińska M, Pierzchała W. Znaczenie badań jakości życia w przewlekłych chorobach układu oddechowego w aspekcie holistycznego pojęcia medycyny. Wiad Lek. 1998; 51: 316–320.
  10. Lewandowska K. Psychologiczne aspekty chorób układu oddechowego — astma oskrzelowa. In: Borys B, Majkowicz M. ed. Psychologia w medycynie. AM w Gdańsku, Gdańsk 2006: 433–441.
  11. Sheridan C, Radmacher S. Psychologia zdrowia. Instytut Psychologii Zdrowia Polskiego Towarzystwa Psychologicznego, Warszawa 1998.
  12. Schier K. Geneza i formy leczenia astmy oskrzelowej: perspektywa psychoanalityczna. Psychoterapia. 2000; 1: 61–71.
  13. Wamboldt FS. Asthma theory and practice: it's not too simple. Fam Process. 2008; 47(1): 131–136.
  14. Purcell K, Brady K, Chai H, et al. The effect on asthma in children of experimental separation from the family. Psychosom Med. 1969; 31(2): 144–164.
  15. Chen E, Chim LS, Strunk RC, et al. The role of the social environment in children and adolescents with asthma. Am J Respir Crit Care Med. 2007; 176(7): 644–649.
  16. Fiese B, Winter M, Anbar R, et al. Family climate of routine asthma care: associating perceived burden and mother-child interaction patterns to child well-being. Fam Process. 2008; 47(1): 63–79.
  17. Klinnert MD, Kaugars AS, Strand M, et al. Family psychological factors in relation to children's asthma status and behavioral adjustment at age 4. Fam Process. 2008; 47(1): 41–61.
  18. Report National Health, Lung and Blood Institute WHO. Światowa Strategia Rozpoznawania, Leczenia i Prewencji Astmy. Med Prakt. 2002: wydanie–specjalne.
  19. Alvarez GG, Fitzgerald JM. A systematic review of the psychological risk factors associated with near fatal asthma or fatal asthma. Respiration. 2007; 74(2): 228–236.
  20. Bass C, Gardner W. Emotional influences on breathing and breathlessness. J Psychosom Res. 1985; 29(6): 599–609.
  21. Papneja T, Manassis K. Characterization and treatment response of anxious children with asthma. Can J Psychiatry. 2006; 51(6): 393–396.
  22. Vila G, Nollet-Clemençon C, de Blic J, et al. Prevalence of DSM IV anxiety and affective disorders in a pediatric population of asthmatic children and adolescents. J Affect Disord. 2000; 58(3): 223–231.
  23. Huovinen E, Kaprio J, Koskenvuo M. Asthma in relation to personality traits, life satisfaction, and stress: a prospective study among 11,000 adults. Allergy. 2001; 56(10): 971–977.
  24. Pietras T, Witusik A, Panek M, et al. Lęk i depresja u pacjentów z chorobami obturacyjnymi płuc. . Pol. Merk. Lek. 2009; XXVI: 631–635.
  25. Dirks JF, Jones NF, Kinsman RA. Panic-fear: a personality dimension related to intractability in asthma. Psychosom Med. 1977; 39(2): 120–126.
  26. Greaves CJ, Eiser C, Seamark D, et al. Attack context: an important mediator of the relationship between psychological status and asthma outcomes. Thorax. 2002; 57(3): 217–221.
  27. Rietveld S, van Beest I, Everaerd W. Stress-induced breathlessness in asthma. Psychol Med. 1999; 29(6): 1359–1366.
  28. Rogiewicz M, Talar J. Psychoterapia u chorych na astmę oskrzelową. Postępy rehabilitacji. 1994; 8: 73–76.
  29. Jażdżewska-Oczadły J, Buczyłko K. Analiza depresji wśród osób z astmą lekką i umiarkowaną. . Przegl. Lek. 2003; 60: 391–394.
  30. Scott KM, Von Korff M, Alonso J, et al. Childhood adversity, early-onset depressive/anxiety disorders, and adult-onset asthma. Psychosom Med. 2008; 70(9): 1035–1043.
  31. Hysing M, Elgen I, Gillberg C, et al. Chronic physical illness and mental health in children. Results from a large-scale population study. J Child Psychol Psychiatry. 2007; 48(8): 785–792.
  32. Breier A. Cognitive deficit in schizophrenia and its neurochemical basis. Br J Psychiatry Suppl. 1999(37): 16–18.
  33. Falkowski A. Spostrzeganie jako mechanizm tworzenia doświadczenia za pomocą zmysłów. In: Strelau J. ed. Psychologia. Podręcznik akademicki. Gdańskie Wydawnictwo Psychologiczne, Gdańsk 2000: 25–55.
  34. Baddeley A. The episodic buffer: a new component of working memory? Trends in Cognitive Sciences. 2000; 4(11): 417–423.
  35. Barch DM, Sheline YI, Csernansky JG, et al. Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression. Biol Psychiatry. 2003; 53(5): 376–384.
  36. Borkowska A, Rybakowski J. Deficyty poznawcze w schizofrenii. In: Borkowska A. ed. Zaburzenia funkcji poznawczych w chorobach psychicznych. Biblioteka Psychiatrii Polskiej, Kraków 2005: 7–29.
  37. Borkowska A, Rybakowski J. Zaburzenia pamięci operacyjnej w schizofrenii i chorobach afektywnych. In: Borkowska A. ed. Zaburzenia funkcji poznawczych w chorobach psychicznych. Biblioteka Psychiatrii Polskiej, Kraków 2005: 45–56.
  38. Borkowska A. Neuropsychologiczne i neurobiologiczne aspekty pamięci operacyjnej. Neuropsychiatria i Neuropsychologia. 2006; 1: 31–42.
  39. Karlsgodt KH, Glahn DC, van Erp TGM, et al. The relationship between performance and fMRI signal during working memory in patients with schizophrenia, unaffected co-twins, and control subjects. Schizophr Res. 2007; 89(1-3): 191–197.
  40. Vetulani J. Pamięć: podstawy neurobiologiczne i możliwość wspomagania. Farmakoter Psych Neurol. 2006; 1: 7–18.
  41. AUDENAERT K, LAHORTE P, BRANS B, et al. The classical Stroop interference task as a prefrontal activation probe: a validation study using 99Tcm-ECD brain SPECT. Nuclear Medicine Communications. 2001; 22(2): 135–143.
  42. Walsh K. Neuropsychologia kliniczna. Wydawnictwo PWN, Warszawa 2000.
  43. Baldo JV, Schwartz S, Wilkins D, et al. Role of frontal versus temporal cortex in verbal fluency as revealed by voxel-based lesion symptom mapping. J Int Neuropsychol Soc. 2006; 12(6): 896–900.
  44. Gouveia PA, Brucki SM, Malheiros SM, et al. Disorders in planning and strategy application in frontal lobe lesion patients. Brain Cogn. 2007; 63(3): 240–246.
  45. Oades R, Bender S, Müller B, et al. Neuropsychological indicators of heteromodal cortex (dys)function relevant to conditioned blocking measures of attention in schizophrenia. Cognitive Neuropsychiatry. 2001; 6(1): 41–61.
  46. Gaillard WD, Hertz-Pannier L, Mott SH, et al. Functional anatomy of cognitive development: fMRI of verbal fluency in children and adults. Neurology. 2000; 54(1): 180–188.
  47. Allen SC, Ragab S. Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad Med J. 2002; 78(915): 37–39.
  48. Stores G, Ellis AJ, Wiggs L, et al. Sleep and psychological disturbance in nocturnal asthma. Arch Dis Child. 1998; 78(5): 413–419.
  49. Moonie S, Sterling DA, Figgs LW, et al. The relationship between school absence, academic performance, and asthma status. J Sch Health. 2008; 78(3): 140–148.
  50. Talarowska M, Florkowski A, Gałecki P, et al. Funkcje poznawcze w depresji. Psychiatr Pol. 2009; 1: 31–40.
  51. Blaiss MS. Allergic Rhinitis in Schoolchildren Consensus Group. Allergic rhinitis and impairment issues in schoolchildren: a consensus report. Curr Med Res Opin. 2004; 20(12): 1937–1952.
  52. Marshall PS, Colon EA. Effects of allergy season on mood and cognitive function. Ann Allergy. 1993; 71(3): 251–258.
  53. BENDER B, FISCHER T. Differential Impacts of Allergic Rhinitis and Allergy Medications on Childhood Learning. Pediatric Asthma, Allergy & Immunology. 1998; 12(1): 1–13.
  54. Blaiss MS. Important aspects in management of allergic rhinitis: compliance, cost, and quality of life. Allergy Asthma Proc. 2003; 24(4): 231–238.
  55. Farnik M, Pierzchała W. Ocena zaburzeń procesów pamięciowych u chorych na obturacyjny bezdech senny. Pneumonol Alergol Pol. 2007; 75: 349–354.
  56. KAY G. The effects of antihistamines on cognition and performance. Journal of Allergy and Clinical Immunology. 2000; 105(6): 622–627.
  57. Wilken JA, Berkowitz R, Kane R. Decrements in vigilance and cognitive functioning associated with ragweed-induced allergic rhinitis. Ann Allergy Asthma Immunol. 2002; 89(4): 372–380.
  58. Ng KH, Chong D, Wong CK, et al. Central nervous system side effects of first- and second-generation antihistamines in school children with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled comparative study. Pediatrics. 2004; 113(2): e116–e121.
  59. Newcomer JW, Craft S, Hershey T, et al. Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci. 1994; 14(4): 2047–2053.
  60. Naber D, Sand P, Heigl B. Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study. Psychoneuroendocrinology. 1996; 21(1): 25–31.
  61. Belanoff JK, Gross K, Yager A, et al. Corticosteroids and cognition. J Psychiatr Res. 2001; 35(3): 127–145.
  62. Brown ES, Frol A, Bobadilla L, et al. Effect of lamotrigine on mood and cognition in patients receiving chronic exogenous corticosteroids. Psychosomatics. 2003; 44(3): 204–208.
  63. Brawley A, Silverman B, Kearney S, et al. Allergic rhinitis in children with attention-deficit/hyperactivity disorder. Ann Allergy Asthma Immunol. 2004; 92(6): 663–667.
  64. McQuaid EL, Weiss-Laxer N, Kopel SJ, et al. Pediatric Asthma and Problems in Attention, Concentration, and Impulsivity: Disruption of the Family Management System. Fam Syst Health. 2008; 26(1): 16–29.
  65. Koinis-Mitchell D, McQuaid EL, Seifer R, et al. Symptom perception in children with asthma: cognitive and psychological factors. Health Psychol. 2009; 28(2): 226–237.
  66. Eriksson UK, Gatz M, Dickman PW, et al. Asthma, eczema, rhinitis and the risk for dementia. Dement Geriatr Cogn Disord. 2008; 25(2): 148–156.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl